将差异性隐私融入深度强化学习中,用于治疗肺炎的败血症,有肺部影响
Shuling Wang1, Feng Yang2, Suixue Wang2
1Department of Neurology, Haikou Affiliated Hospital of Central South University Xiangya School of Medicine, Haikou, China.
Frontiers in medicine
|May 2, 2025
概括
这项研究引入了在败血症治疗中深度强化学习 (DRL) 的差异隐私方法,保护患者数据和模型完整性,同时有效地管理肺损伤.
科学领域:
- 人工智能在医学中的应用
- 计算生物学 计算生物学
- 医疗信息学 医疗信息学
背景情况:
- 败血症,特别是肺炎等肺部疾病,可以启动免疫功能障碍和肺组织损伤的有害循环.
- 深度强化学习 (DRL) 显示出优化败血症治疗策略的前景.
- 保护敏感的培训数据和专有DRL模型至关重要,因为这将增加在线可访问性和商业价值.
研究的目的:
- 开发一个维护隐私的DRL模型用于临床败血症治疗计划.
- 评估差异性隐私机制对 DRL 败血症模型的性能影响.
- 为了实现安全和有效的败血症治疗设计,减轻不良的肺结局.
主要方法:
- 实现与DRL模型集成的差异性隐私框架.
- 系统地调查差异性隐私机制如何影响DRL模型在败血症治疗中的性能.
- 拟议的保护隐私的DRL方法的实验验证.
主要成果:
- 拟议的基于差异隐私的DRL模型有效地保护了患者数据和DRL模型的"隐私".
- 差异性隐私集成显示了对DRL模型治疗败血症的性能有可管理的影响.
- 这种方法有助于安全的临床决策对于败血症管理.
结论:
- 差异隐私是一种可行的方法,可以确保在败血症治疗中使用的DRL模型.
- 这项技术使临床医生能够创建个性化的败血症治疗计划,同时确保患者的保密性.
- 整合保护隐私的人工智能可以减轻败血症引起的肺损伤,并改善患者的治疗结果.
相关概念视频
01:28Pneumonia IV: Management
263
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
263
01:30Pneumonia III: Complications and Assessment
116
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
116
01:29Acute Respiratory Failure-V
102
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
102